Meeting Banner
Abstract #3432

Monitoring PKM2 Status in Glioblastoma Using Hyperpolarized 13C MRS

Myriam Marianne Chaumeil1, Joydeep Mukherjee2, Humsa Venkatesh1, Russell O. Pieper2, Sabrina M. Ronen1

1Radiology, University of California, San Francisco, San Francisco, CA, United States; 2Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States

The M2 isoform of pyruvate kinase (PKM2) induces a reprogramming of energetic metabolism in cancer cells, leading to tumor growth and metastasis. Because PKM2 modulation is being investigated as a therapeutic approach, we questioned whether hyperpolarized (HP) 13C MRS of pyruvate could serve as a method to probe the PKM2 status. This study shows that knocking down PKM2 expression in glioblastoma cells leads to a significant decrease in HP lactate formation. HP 13C MRS of pyruvate could thus prove useful for evaluation of new PKM2-targeted therapies.

Keywords

accordingly acid acidification acids acknowledgments activity aerobic alanine allowed amino assay assessed association beads bicarbonate blocks blot blue brain briefly buffer building cancer catalyzes cell cells central chemical circulated coding complex concentration confirmed consistent constant control controls conversion converts coupled courses cultured described detected drop dropped enhanced enzymatic enzyme enzymes equations every express expression facilitates fellowship final formation generated glucose green grown highlighted hour hydrate illustrates importantly indirectly injected injection insert intensities kinetic knockdown knocked lactate lead leading live loaded material measured mediating medium metabolic metabolism metastasis mind models modified modulation monitor monitored nature necessary neurological noise normalized oxidative peaks perfused perfusion physical plays plot polarizer polyethylene post previously prior probed processing production prove providing pseudo quantification questioned radiology role samples schematic science scrambled serve significantly software specifically spectra spore status studies substrate supplemented supplied surgery switch system therapeutic therapies transduction treatment tube tumor useful valve viability ward western whereas whether